Isorhamnetin
CAS No. 480-19-3
Isorhamnetin( 3'-O-methyl Quercetin )
Catalog No. M14602 CAS No. 480-19-3
Red turnip,goldenrod,mustard leaf,ginkgo biloba.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 74 | In Stock |
|
| 5MG | 71 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 235 | In Stock |
|
| 50MG | 384 | In Stock |
|
| 100MG | 549 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1181 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIsorhamnetin
-
NoteResearch use only, not for human use.
-
Brief DescriptionRed turnip,goldenrod,mustard leaf,ginkgo biloba.
-
DescriptionRed turnip,goldenrod,mustard leaf,ginkgo biloba.(In Vitro):Isorhamnetin is a plant flavonoid that occurs in fruits and medicinal herbs. Isorhamnetin binds directly to MEK1 in an ATP-noncompetitive manner and to PI3-K in an ATP-competitive manner. In vitro and ex vivo kinase assay data show that Isorhamnetin inhibits the kinase activity of MAP/ERK kinase (MEK) 1 and PI3-K and the inhibition is due to direct binding with Isorhamnetin. Isorhamnetin inhibits the Akt/mTOR and MEK/ERK signaling pathways, and promotes the activity of the mitochondrial apoptosis signaling pathway. The inhibitory effects of Isorhamnetin on breast cancer cells are determined using the CCK-8 method. Isorhamnetin inhibits the proliferation of numerous breast cancer cells (IC50, ~10 μM), including MCF7, T47D, BT474, BT-549, MDA-MB-231 and MDA-MB-468, whereas less inhibitory activity is observed in the MCF10A normal breast epithelial cell line (IC50, 38 μM).(In Vivo):Photographic data shows that Isorhamnetin treatment suppresses tumor development in mice. The average volume of tumors in untreated mice increases over time and reaches a volume of 623 mm3 at 4 weeks post-inoculation; however, at this time, in mice treated with 1 or 5 mg/kg Isorhamnetin, the average tumor volume is only 280 or 198 mm3, respectively. At the end of the study, Isorhamnetin treatment (1 or 5 mg/kg) reduces tumor weight compared with the untreated control group.
-
In Vitro——
-
In Vivo——
-
Synonyms3'-O-methyl Quercetin
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number480-19-3
-
Formula Weight316.27
-
Molecular FormulaC16H12O7
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C1C(O)=C(C2=CC=C(O)C(OC)=C2)OC3=CC(O)=CC(O)=C13
-
Chemical Name3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-chromen-4-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Han X, et al. Biomol Ther (Seoul). 2015 Jul;23(4):357-66.
molnova catalog
related products
-
RI-STAD 2
AKAP disruptor. Selectively binds PKA-RI with high affinity (KD values are 6.2 and 12.1 nM for the RIα and β subunits, respectively) and blocks its interaction with AKAP. Inhibits type I PKA-mediated phosphorylation in live cells. Cell permeable.
-
(S,R,S)-AHPC-PEG4-N3
(S,R,S)-AHPC-PEG4-N3 is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 4-unit PEG linker used in PROTAC technology.
-
[Met5, Lys6] a-Neo-E...
[Met5, Lys6] a-Neo-Endorphin (1-6)
Cart
sales@molnova.com